<VariationArchive RecordType="classified" VariationID="6322" VariationName="NG_011542.1:g.(18884_24404)_(24462_27018)del" VariationType="Deletion" Accession="VCV000006322" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-31" DateCreated="2013-04-08" MostRecentSubmission="2013-04-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21361" VariationID="6322">
      <GeneList>
        <Gene Symbol="ASS1" FullName="argininosuccinate synthase 1" GeneID="445" HGNC_ID="HGNC:758" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="130444707" stop="130501274" display_start="130444707" display_stop="130501274" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="133320093" stop="133376660" display_start="133320093" display_stop="133376660" Strand="+" />
          </Location>
          <OMIM>603470</OMIM>
        </Gene>
      </GeneList>
      <Name>NG_011542.1:g.(18884_24404)_(24462_27018)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.1</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>EX6DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.(130458590_130464110)_(130464168_130466724)del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.(130458590_130464110)_(130464168_130466724)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011542.1" sequenceAccession="NG_011542" sequenceVersion="1" change="g.(18884_24404)_(24462_27018)del">
            <Expression>NG_011542.1:g.(18884_24404)_(24462_27018)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603470.0002" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_011542.1:g.(18884_24404)_(24462_27018)del AND Citrullinemia type I" Accession="RCV000006694" Version="3">
        <ClassifiedConditionList TraitSetID="1757">
          <ClassifiedCondition DB="MedGen" ID="C4721769">Citrullinemia type I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1995-10-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-08" MostRecentSubmission="2013-04-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Kobayashi, K., Jackson, M. J., Tick, D. B., O'Brien, W. E., Beaudet, A. L. Characterization of nine mutant alleles causing citrullinemia. (Abstract) Am. J. Hum. Genet. 45 (suppl.): A201-only, 1989.</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7557970</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1757" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1459" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">argininosuccinate synthetase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Classic citrullinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ASS deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Citrullinemia 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Citrullinemia type I</ElementValue>
                <XRef ID="Citrullinemia+Type+I/1651" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008988" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CTNL1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CTLN1</ElementValue>
                <XRef Type="MIM" ID="215700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Citrullinemia type I (CTLN1) presents as a spectrum that includes a neonatal acute form (the "classic" form), a milder late-onset form (the "non-classic" form), a form in which women have onset of symptoms at pregnancy or post partum, and a form without symptoms or hyperammonemia. Distinction between the forms is based primarily on clinical findings, although emerging evidence suggests that measurement of residual argininosuccinate synthase enzyme activity may help to predict those who are likely to have a severe phenotype and those who are likely to have an attenuated phenotype. Infants with the acute neonatal form appear normal at birth. Shortly thereafter, they develop hyperammonemia and become progressively lethargic, feed poorly, often vomit, and may develop signs of increased intracranial pressure (ICP). Without prompt intervention, hyperammonemia and the accumulation of other toxic metabolites (e.g., glutamine) result in increased ICP, increased neuromuscular tone, spasticity, ankle clonus, seizures, loss of consciousness, and death. Children with the severe form who are treated promptly may survive for an indeterminate period of time, but usually with significant neurologic deficits. Even with chronic protein restriction and scavenger therapy, long-term complications such as liver failure and other (rarely reported) organ system manifestations are possible. The late-onset form may be milder than that seen in the acute neonatal form, but commences later in life for reasons that are not completely understood. The episodes of hyperammonemia are similar to those seen in the acute neonatal form, but the initial neurologic findings may be more subtle because of the older age of the affected individuals. Women with onset of severe symptoms including acute hepatic decompensation during pregnancy or in the postpartum period have been reported. Furthermore, previously asymptomatic and non-pregnant individuals have been described who remained asymptomatic up to at least age ten years, with the possibility that they could remain asymptomatic lifelong.</Attribute>
                <XRef ID="NBK1458" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301631</ID>
                <ID Source="BookShelf">NBK1458</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301396</ID>
                <ID Source="BookShelf">NBK1217</ID>
              </Citation>
              <XRef ID="247525" DB="Orphanet" />
              <XRef ID="C4721769" DB="MedGen" />
              <XRef ID="MONDO:0008988" DB="MONDO" />
              <XRef Type="MIM" ID="215700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26885" SubmissionDate="2013-04-04" DateLastUpdated="2013-04-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603470.0002_CITRULLINEMIA, CLASSIC" title="ASS1, EX6DEL_CITRULLINEMIA, CLASSIC" />
        <ClinVarAccession Accession="SCV000026885" DateUpdated="2013-04-08" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Kobayashi et al. (1989) demonstrated deletion of exon 6 in the ASS gene in a case of citrullinemia (215700). Kobayashi et al. (1995) stated that this is a deletion of 2-3 kb, including the 57-bp exon 6.</Attribute>
              <Citation>
                <CitationText>Kobayashi, K., Jackson, M. J., Tick, D. B., O'Brien, W. E., Beaudet, A. L. Characterization of nine mutant alleles causing citrullinemia. (Abstract) Am. J. Hum. Genet. 45 (suppl.): A201-only, 1989.</CitationText>
              </Citation>
              <Citation>
                <ID Source="PubMed">7557970</ID>
              </Citation>
              <XRef DB="OMIM" ID="215700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASS1" />
          </GeneList>
          <Name>ASS1, EX6DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX6DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603470.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CITRULLINEMIA, CLASSIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26885" TraitType="Disease" MappingType="Name" MappingValue="CITRULLINEMIA, CLASSIC" MappingRef="Preferred">
        <MedGen CUI="C4721769" Name="Citrullinemia type I" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

